Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Nov;119(6):1125–1130. doi: 10.1111/j.1476-5381.1996.tb16013.x

EndothelinB receptor-mediated contraction in human pulmonary resistance arteries.

K M McCulloch 1, C C Docherty 1, I Morecroft 1, M R MacLean 1
PMCID: PMC1915906  PMID: 8937714

Abstract

1. Using wire myography, we have examined the endothelin (ET) receptor subtypes mediating vasoconstriction to ET peptides in human pulmonary resistance arteries (150-200 microns, i.d.). 2. Cumulative concentration-response curves to ET-1, sarafotoxin 6c (SX6c) and ET-3 were constructed in the presence and absence of the selective antagonists FR 139317 (ETA-selective), BMS 182874 (ETA-selective) and BQ-788 (ETB-selective). 3. All agonists induced concentration-dependent contractions. However, the response curves to ET-1 were biphasic in nature. The first component demonstrated a shallow slope up to 1 nM ET-1. Above 1 nM ET-1 the response curve was markedly steeper. Maximum responses to ET-3 and SX6c were the same as those to 1 nM ET-1 and 30% of those to 0.1 microM ET-1. The order of potency, taking 0.3 microM as a maximum concentration was SX6c >> ET-3 > ET-1 (pEC50 values of: 10.75 +/- 0.27, 9.05 +/- 0.19, 8.32 +/- 0.08 respectively). Taking 1 nM ET-1 as a maximum, the EC50 for ET-1 was 10.08 +/- 0.13 and therefore ET-1 was equipotent to ET-3 and SX6c over the first component of the response curve. 4. Responses to ET-1 up to 1 nM were resistant to the effects of the ETA receptor antagonists, FR 139317 and BMS 182874 but were inhibited by the ETB receptor antagonist, BQ-788. Conversely, responses to ET-1 over 1 nM were inhibited by the ETA receptor antagonists, FR 139317 and BMS 182874 but unaffected by the ETB receptor antagonist, BQ-788. 5. The results suggest that at concentrations up to 1 nM, responses to ET-1 are mediated via the ETB receptor, whilst the responses to higher concentrations are mediated by ETA receptors.

Full text

PDF
1125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cacoub P., Dorent R., Maistre G., Nataf P., Carayon A., Piette C., Godeau P., Cabrol C., Gandjbakhch I. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol. 1993 Feb 15;71(5):448–450. doi: 10.1016/0002-9149(93)90452-i. [DOI] [PubMed] [Google Scholar]
  2. Chang H., Wu G. J., Wang S. M., Hung C. R. Plasma endothelin levels and surgically correctable pulmonary hypertension. Ann Thorac Surg. 1993 Feb;55(2):450–458. doi: 10.1016/0003-4975(93)91018-i. [DOI] [PubMed] [Google Scholar]
  3. Cody R. J., Haas G. J., Binkley P. F., Capers Q., Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 1992 Feb;85(2):504–509. doi: 10.1161/01.cir.85.2.504. [DOI] [PubMed] [Google Scholar]
  4. Dashwood M. R., Timm M., Kaski J. C. Regional variations in ETA/ETB binding sites in human coronary vasculature. J Cardiovasc Pharmacol. 1995;26 (Suppl 3):S351–S354. [PubMed] [Google Scholar]
  5. Davenport A. P., Maguire J. J. Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans? Trends Pharmacol Sci. 1994 Jan;15(1):9–11. doi: 10.1016/0165-6147(94)90120-1. [DOI] [PubMed] [Google Scholar]
  6. Eddahibi S., Raffestin B., Braquet P., Chabrier P. E., Adnot S. Pulmonary vascular reactivity to endothelin-1 in normal and chronically pulmonary hypertensive rats. J Cardiovasc Pharmacol. 1991;17 (Suppl 7):S358–S361. doi: 10.1097/00005344-199100177-00102. [DOI] [PubMed] [Google Scholar]
  7. Ferri C., Bellini C., De Angelis C., De Siati L., Perrone A., Properzi G., Santucci A. Circulating endothelin-1 concentrations in patients with chronic hypoxia. J Clin Pathol. 1995 Jun;48(6):519–524. doi: 10.1136/jcp.48.6.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fishman A. P. Hypoxia on the pulmonary circulation. How and where it acts. Circ Res. 1976 Apr;38(4):221–231. doi: 10.1161/01.res.38.4.221. [DOI] [PubMed] [Google Scholar]
  9. Fukuroda T., Kobayashi M., Ozaki S., Yano M., Miyauchi T., Onizuka M., Sugishita Y., Goto K., Nishikibe M. Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J Appl Physiol (1985) 1994 May;76(5):1976–1982. doi: 10.1152/jappl.1994.76.5.1976. [DOI] [PubMed] [Google Scholar]
  10. Fukuroda T., Ozaki S., Ihara M., Ishikawa K., Yano M., Miyauchi T., Ishikawa S., Onizuka M., Goto K., Nishikibe M. Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi. Br J Pharmacol. 1996 Mar;117(6):995–999. doi: 10.1111/j.1476-5381.1996.tb16688.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fukuroda T., Ozaki S., Ihara M., Ishikawa K., Yano M., Nishikibe M. Synergistic inhibition by BQ-123 and BQ-788 of endothelin-1-induced contractions of the rabbit pulmonary artery. Br J Pharmacol. 1994 Oct;113(2):336–338. doi: 10.1111/j.1476-5381.1994.tb16901.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Giaid A., Yanagisawa M., Langleben D., Michel R. P., Levy R., Shennib H., Kimura S., Masaki T., Duguid W. P., Stewart D. J. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993 Jun 17;328(24):1732–1739. doi: 10.1056/NEJM199306173282402. [DOI] [PubMed] [Google Scholar]
  13. Goerre S., Wenk M., Bärtsch P., Lüscher T. F., Niroomand F., Hohenhaus E., Oelz O., Reinhart W. H. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation. 1995 Jan 15;91(2):359–364. doi: 10.1161/01.cir.91.2.359. [DOI] [PubMed] [Google Scholar]
  14. Hassoun P. M., Thappa V., Landman M. J., Fanburg B. L. Endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc Soc Exp Biol Med. 1992 Feb;199(2):165–170. doi: 10.3181/00379727-199-43342. [DOI] [PubMed] [Google Scholar]
  15. Haynes W. G., Strachan F. E., Webb D. J. Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation. 1995 Aug 1;92(3):357–363. doi: 10.1161/01.cir.92.3.357. [DOI] [PubMed] [Google Scholar]
  16. Itoh H., Hiraoka N., Higuchi H., Ito M., Konishi T., Nakano T. Contractile actions of endothelin-1 in isolated helical strips from rat pulmonary artery: potentiation of serotonin-induced contraction. J Cardiovasc Pharmacol. 1992 Jul;20(1):1–6. [PubMed] [Google Scholar]
  17. Janakidevi K., Fisher M. A., Del Vecchio P. J., Tiruppathi C., Figge J., Malik A. B. Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am J Physiol. 1992 Dec;263(6 Pt 1):C1295–C1301. doi: 10.1152/ajpcell.1992.263.6.C1295. [DOI] [PubMed] [Google Scholar]
  18. Karne S., Jayawickreme C. K., Lerner M. R. Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. J Biol Chem. 1993 Sep 5;268(25):19126–19133. [PubMed] [Google Scholar]
  19. Kiowski W., Sütsch G., Hunziker P., Müller P., Kim J., Oechslin E., Schmitt R., Jones R., Bertel O. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet. 1995 Sep 16;346(8977):732–736. doi: 10.1016/s0140-6736(95)91504-4. [DOI] [PubMed] [Google Scholar]
  20. LaDouceur D. M., Flynn M. A., Keiser J. A., Reynolds E., Haleen S. J. ETA and ETB receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction. Biochem Biophys Res Commun. 1993 Oct 15;196(1):209–215. doi: 10.1006/bbrc.1993.2236. [DOI] [PubMed] [Google Scholar]
  21. Lam H. C., Takahashi K., Ghatei M. A., Warrens A. N., Rees A. J., Bloom S. R. Immunoreactive endothelin in human plasma, urine, milk, and saliva. J Cardiovasc Pharmacol. 1991;17 (Suppl 7):S390–S393. doi: 10.1097/00005344-199100177-00109. [DOI] [PubMed] [Google Scholar]
  22. Langleben D., DeMarchie M., Laporta D., Spanier A. H., Schlesinger R. D., Stewart D. J. Endothelin-1 in acute lung injury and the adult respiratory distress syndrome. Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1646–1650. doi: 10.1164/ajrccm/148.6_Pt_1.1646. [DOI] [PubMed] [Google Scholar]
  23. Li H., Chen S. J., Chen Y. F., Meng Q. C., Durand J., Oparil S., Elton T. S. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J Appl Physiol (1985) 1994 Sep;77(3):1451–1459. doi: 10.1152/jappl.1994.77.3.1451. [DOI] [PubMed] [Google Scholar]
  24. MacLean M. R., McCulloch K. M., Baird M. Effects of pulmonary hypertension on vasoconstrictor responses to endothelin-1 and sarafotoxin S6C and on inherent tone in rat pulmonary arteries. J Cardiovasc Pharmacol. 1995 Nov;26(5):822–830. doi: 10.1097/00005344-199511000-00020. [DOI] [PubMed] [Google Scholar]
  25. MacLean M. R., McCulloch K. M., Baird M. Endothelin ETA- and ETB-receptor-mediated vasoconstriction in rat pulmonary arteries and arterioles. J Cardiovasc Pharmacol. 1994 May;23(5):838–845. doi: 10.1097/00005344-199405000-00022. [DOI] [PubMed] [Google Scholar]
  26. MacLean M. R., McGrath J. C. Effects of pre-contraction with endothelin-1 on alpha 2-adrenoceptor- and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated vascular bed of the rat tail. Br J Pharmacol. 1990 Sep;101(1):205–211. doi: 10.1111/j.1476-5381.1990.tb12114.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Maguire J. J., Davenport A. P. ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br J Pharmacol. 1995 May;115(1):191–197. doi: 10.1111/j.1476-5381.1995.tb16338.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. McCulloch K. M., MacLean M. R. EndothelinB receptor-mediated contraction of human and rat pulmonary resistance arteries and the effect of pulmonary hypertension on endothelin responses in the rat. J Cardiovasc Pharmacol. 1995;26 (Suppl 3):S169–S176. [PubMed] [Google Scholar]
  29. Miyauchi T., Sugishita Y., Yamaguchi I., Ajisaka R., Tomizawa T., Onizuka M., Matsuda M., Kono I., Yanagisawa M., Goto K. Plasma concentrations of endothelin-1 and endothelin-3 are altered differently in various pathophysiological conditions in humans. J Cardiovasc Pharmacol. 1991;17 (Suppl 7):S394–S397. doi: 10.1097/00005344-199100177-00110. [DOI] [PubMed] [Google Scholar]
  30. Mulvany M. J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977 Jul;41(1):19–26. doi: 10.1161/01.res.41.1.19. [DOI] [PubMed] [Google Scholar]
  31. Nootens M., Kaufmann E., Rector T., Toher C., Judd D., Francis G. S., Rich S. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol. 1995 Dec;26(7):1581–1585. doi: 10.1016/0735-1097(95)00399-1. [DOI] [PubMed] [Google Scholar]
  32. Peacock A. J., Dawes K. E., Shock A., Gray A. J., Reeves J. T., Laurent G. J. Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol. 1992 Nov;7(5):492–499. doi: 10.1165/ajrcmb/7.5.492. [DOI] [PubMed] [Google Scholar]
  33. Pittman R. N., Duling B. R. Oxygen sensitivity of vascular smooth muscle. I. In vitro studies. Microvasc Res. 1973 Sep;6(2):202–211. doi: 10.1016/0026-2862(73)90020-4. [DOI] [PubMed] [Google Scholar]
  34. Pussard G., Gascard J. P., Gorenne I., Labat C., Norel X., Dulmet E., Brink C. Endothelin-1 modulates cyclic GMP production and relaxation in human pulmonary vessels. J Pharmacol Exp Ther. 1995 Aug;274(2):969–975. [PubMed] [Google Scholar]
  35. Seo B., Oemar B. S., Siebenmann R., von Segesser L., Lüscher T. F. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation. 1994 Mar;89(3):1203–1208. doi: 10.1161/01.cir.89.3.1203. [DOI] [PubMed] [Google Scholar]
  36. Stewart D. J., Levy R. D., Cernacek P., Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med. 1991 Mar 15;114(6):464–469. doi: 10.7326/0003-4819-114-6-464. [DOI] [PubMed] [Google Scholar]
  37. Takeshita H., Nishikibe M., Yano M., Ikemoto F. Coronary vascular response to endothelin in isolated perfused hearts of spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1991 Sep;18(9):661–669. doi: 10.1111/j.1440-1681.1991.tb01640.x. [DOI] [PubMed] [Google Scholar]
  38. Vincent J. A., Ross R. D., Kassab J., Hsu J. M., Pinsky W. W. Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood flow. Am J Cardiol. 1993 May 15;71(13):1204–1207. doi: 10.1016/0002-9149(93)90646-t. [DOI] [PubMed] [Google Scholar]
  39. Wagner O. F., Christ G., Wojta J., Vierhapper H., Parzer S., Nowotny P. J., Schneider B., Waldhäusl W., Binder B. R. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem. 1992 Aug 15;267(23):16066–16068. [PubMed] [Google Scholar]
  40. White D. G., Garratt H., Mundin J. W., Sumner M. J., Vallance P. J., Watts I. S. Human saphenous vein contains both endothelin ETA and ETB contractile receptors. Eur J Pharmacol. 1994 May 23;257(3):307–310. doi: 10.1016/0014-2999(94)90144-9. [DOI] [PubMed] [Google Scholar]
  41. Wong J., Vanderford P. A., Winters J., Soifer S. J., Fineman J. R. Endothelinb receptor agonists produce pulmonary vasodilation in intact newborn lambs with pulmonary hypertension. J Cardiovasc Pharmacol. 1995 Feb;25(2):207–215. doi: 10.1097/00005344-199502000-00005. [DOI] [PubMed] [Google Scholar]
  42. Yamamoto K., Ikeda U., Mito H., Fujikawa H., Sekiguchi H., Shimada K. Endothelin production in pulmonary circulation of patients with mitral stenosis. Circulation. 1994 May;89(5):2093–2098. doi: 10.1161/01.cir.89.5.2093. [DOI] [PubMed] [Google Scholar]
  43. Yorikane R., Miyauchi T., Sakai S., Sakurai T., Yamaguchi I., Sugishita Y., Goto K. Altered expression of ETB-receptor mRNA in the lung of rats with pulmonary hypertension. J Cardiovasc Pharmacol. 1993;22 (Suppl 8):S336–S338. doi: 10.1097/00005344-199322008-00088. [DOI] [PubMed] [Google Scholar]
  44. Yoshibayashi M., Nishioka K., Nakao K., Saito Y., Matsumura M., Ueda T., Temma S., Shirakami G., Imura H., Mikawa H. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation. 1991 Dec;84(6):2280–2285. doi: 10.1161/01.cir.84.6.2280. [DOI] [PubMed] [Google Scholar]
  45. Yoshimoto S., Ishizaki Y., Sasaki T., Murota S. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke. 1991 Mar;22(3):378–383. doi: 10.1161/01.str.22.3.378. [DOI] [PubMed] [Google Scholar]
  46. Zhu Z. G., Wang M. S., Jiang Z. B., Jiang Z., Xu S. X., Ren C. Y., Shi M. X. The dynamic change of plasma endothelin-1 during the perioperative period in patients with rheumatic valvular disease and secondary pulmonary hypertension. J Thorac Cardiovasc Surg. 1994 Nov;108(5):960–968. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES